(Q64019049)

1

0 references

J.F.R. Robertson

2

0 references

C.W. Elston

4

0 references

R.W. Blarney

Treatment of cancer in the elderly

5

0 references

publication date

December 1998

0 references

published in

The Breast

0 references

volume

7

0 references

issue

6

0 references

page(s)

335-339

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Breast carcinoma in the elderly patient: An assessment of operative risk, morbidity and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Change in the oestrogen receptor status of breast cancer with age--comparison of two types of assay

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen only

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Immunocytochemical staining of pS2 protein in fine-needle aspirate from breast cancer is an accurate guide to response to tamoxifen in patients aged over 70 years

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

The prediction of local or regional recurrence after simple mastectomy for operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021

Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9776%2898%2990077-7

7 January 2021